MOHNYSEHospital & Medical Service PlansFiscal year ends December 31

MOLINA HEALTHCARE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 22, 2026

$210.20+2.84 (+1.37%)

Close on Oct 19, 2026

Market cap: $10.78B
P/E (TTM): –
Dividend yield: –

MOLINA HEALTHCARE, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	45,426	40,650	34,072	31,974	27,771	19,423	16,829	18,890	19,883	17,782	14,178	9,667	6,589	5,914	4,540	4,086	3,669
Cost of Revenue	39,488	34,428	28,669	27,175	23,704	15,820	13,905	–	–	–	–	–	–	–	–	–	–
Gross Profit	5,938	6,222	5,403	4,799	4,067	2,479	2,303	2,518	1,810	1,725	1,527	1,000	843	–	–	–	–
General & Administrative	3,009	2,743	2,462	2,311	2,068	1,480	1,296	1,333	1,594	1,393	1,146	765	666	519	393	346	276
Total Costs & Expenses	44,645	38,943	32,499	30,801	26,751	18,345	15,785	17,759	20,438	17,476	13,791	9,474	6,452	5,873	4,404	3,981	3,619
Operating Income	781	1,707	1,573	1,173	1,020	1,078	1,044	1,131	-555	306	387	193	137	41	136	105	52
Interest Expense	192	118	109	110	120	102	87	115	118	101	66	57	52	17	16	16	14
Other Non-Operating Income	–	–	-109	-110	-145	-117	-72	-132	-57	-101	-65	-58	-56	-18	-16	-16	–
Merger & Restructuring Charges	–	–	–	–	–	–	6.00	46	234	0	0	–	–	–	–	–	–
Asset Impairment Charges	–	0	0	208	0	0	0	0	470	0	0	0	0	0	65	0	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	0	0	-15	0	0	–	0	0	1.75	0	0	–
Pretax Income	589	1,589	1,464	1,063	875	961	972	999	-612	205	322	135	81	23	120	89	38
Income Tax Expense	117	410	373	271	216	288	235	292	-100	153	179	73	36	11	43	35	7.29
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	143	62	45	13	77	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	–	0	0	8.00	-3.08	-57	–	–
Net Income	472	1,179	1,091	792	659	673	737	707	-512	52	143	62	53	9.79	21	55	31
EPS (Basic)(per share)	8.93	20.52	18.91	13.72	11.40	11.40	11.85	11.57	-9.07	0.93	2.75	1.33	1.16	0.21	0.45	1.34	0.80
EPS (Diluted)(per share)	8.92	20.42	18.77	13.55	11.25	11.23	11.47	10.61	-9.07	0.92	2.58	1.29	1.13	0.21	0.45	1.32	0.79
Shares Outstanding (Basic, Weighted)(shares)	53	57	58	58	58	59	62	61	56	55	52	47	46	46	46	0.04	39
Shares Outstanding (Diluted, Weighted)(shares)	53	58	58	59	59	60	64	67	56	56	56	48	47	47	46	0.04	39
EBITDA	976	1,893	1,744	1,349	1,151	1,166	1,133	1,258	-377	488	513	327	231	120	210	166	90
Total Interest Income	–	–	–	75	77	17	17	125	70	38	23	20	7.00	5.08	5.45	6.26	9.15
Premiums Earned	43,052	38,627	32,529	30,883	26,855	18,299	16,208	17,612	18,854	16,445	–	–	–	–	–	–	–
Net Investment Income	420	452	394	143	52	59	115	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 12.6%
Operating margin: 0.5%
Net margin: -0.0%
Return on equity, FY2025: 11.0%

Financial strength

Current ratio: 1.68
Debt to equity: 0.90
Debt to assets: 23.6%
Cash to current liabilities: 64.7%

Valuation

P/E ratio: –
Price to sales: 0.24
Price to book: 2.59
Dividend yield: –